Photosonix Medical
2014
FOUNDED
PRIVATE
STATUS
1-10
EMPLOYEES
Seed
LATEST DEAL TYPE
$2.39M
LATEST DEAL AMOUNT
4
INVESTORS
Description
Developer of a skin care treatment device designed to provide treatment for acne at home. The company's skin care treatment device offers CLENS which combines low level ultrasound stimulation with blue light energy to achieve a strong anti-bacterial effect, especially in chronic bacterial infections known as biofilms, enabling users to prevent permanent skin scarring.
Website
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Therapeutic Devices
Other Industries
Other Healthcare Services
Primary Office
- 580 Virginia Drive
- Suite 230
- Fort Washington, PA 19034
- United States
+1 (267) 000-0000
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore Photosonix Medical’s full profile, request a free trial.
Photosonix Medical Valuation and Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Seed Round | 15-Mar-2017 | $2.39M | 00.000 | Completed | Startup | |
| 2. Grant | 31-Oct-2014 | 00000 | 00000 | Completed | Startup | |
| 1. Debt - General | 30-Sep-2014 | $100K | $100K | Completed | Startup |
Photosonix Medical Investors (4)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Board Seat |
Contact Info |
|---|---|---|---|---|---|---|
| Ben Franklin Technology Partners of Southeastern Pennsylvania | Venture Capital | Minority | 000 0000 | 000000 0 | ||
| Delaware Crossing Investor Group | Angel Group | Minority | 000 0000 | 000000 0 | ||
| Princeton Biopharma Capital Partners | PE/Buyout | Minority | 000 0000 | 000000 0 | ||
| National Institutes of Health | Government | 000 0000 | 000000 0 |
Photosonix Medical Executive Team (4)
Photosonix Medical Board Members (2)
| Name | Representing | Role | Since | Contact Info |
|---|---|---|---|---|
| Charles Hadley JD | Self | Board Member | 000 0000 | |
| Michael Wells | Princeton Biopharma Capital Partners | Board Member | 000 0000 |